An ICR team has unveiled a cutting-edge research platform powered by artificial intelligence (AI) that will revolutionise cancer research by allowing researchers to integrate and analyse large and complex clinical trial datasets, speeding up the discovery of new cancer biomarkers.

Doctors could soon be able to better predict an individual patient’s chances of getting cancer and offer them personalised detection and prevention strategies, thanks to a new research project co-led by scientists at The Institute of Cancer Research, London.